These were stem cell factor (1.33-fold, p = 0.033), interleukin-6 receptor alpha (1.4-fold, p = 0.004), chemokine ligand 19 (1.9-fold, p = 0.038), melanoma inhibitory activity (1.32-fold, p = 0.040) and VEGF-D (1.75-fold, p = 0.034). This evidence concerns the gene VEGFD and melanoma.